Skip to main content

Table 1 Demographic Data and Clinical Features of the Groups

From: Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels

Characteristics

PCOS (n = 46)

PCOS + HT (n = 46)

P value

Age, mean ± SD, years

26.4 ± 3.8

27.7 ± 3.2

0.072

Body mass index, mean ± SD, kg/m2

26.8 ± 5.4

27.1 ± 4.7

0.773

Waist/hip ratio, mean ± SD

0.75 ± 0.06

0.76 ± 0.07

0.737

Cigarette, n(%)

 No

22 (47.8)

25 (54.3)

0.532

 Yes

24 (52.2)

21 (45.7)

Chronic disease, n(%)

 No

39 (84.8)

29 (63)

0.060

 Asthma

5 (10.9)

7 (15.2)

 Diabetes type 2

0

2 (4.3)

 Other

2 (4.3)

8 (17.4)

Chronic Medication Use, n(%)

 No

38 (82.6)

29 (63)

0.035

 Yes

8 (17.4)

17 (37)

Menarche Age, mean ± SD, years

13 ± 1.1

13.2 ± 1.2

0.52

Menstrual Pattern, n(%)

 Regular

7 (15.3)

12 (26.1)

0.260

 Oligo/ amenorrhea

37 (80.4)

33 (71.7)

 Polymenorrhea

2 (4.3)

1 (2.2)

Acne, n(%)

 No

23 (50)

26 (56.5)

0.457

 Yes

23 (50)

19 (41.3)

Hirsutism Score (mean ± SD)

8.2 ± 4.8

8.5 ± 4.3

0.787

Fertility n(%)

 Fertile

20 (43.5)

8 (17.4)

0.007

 Pr. infertile

15 (32.6)

29 (63)

 Sec. infertile

11 (23.9)

9 (19.6)

İnfertility period, year±SD

2.2 ± 1.5

2.5 ± 2.7

0.477

Gravida

1 (0–4)

0 (0–3)

< 0.001

Parity

1 (0–3)

0 (0–3)

< 0.001

Abortion

0 (0–2)

0 (0–1)

0.14

Family history of autoimmune thyroiditis, n(%)

 No

35 (76.1)

20 (43.5)

0.001

 Yes

11 (23.9)

26 (56.5)

Family history of autoimmune disease, n(%)

 No

26 (56.5)

21 (45.7)

0.297

 Yes

20 (43.5)

25 (54.3)

HT period, year, median (min-max) mean ± SD

0

1.5 (0–10)

2.6 ± 2.9

 

Thyroid Hormone Replacement (THR), n(%)

 No

46 (100)

20 (43.5)

 

< 0.001

 Yes

0

26 (56.5)

 

THR time, year

0

1 (0–16)

2.1 ± 3.2

 
  1. SD Standard deviation, PCOS Polycystic ovary syndrome, HT Hashimoto’s Thyroiditis